Leadership
The Program in Cellular and Molecular Medicine and Immune Disease Institute (PCMM/IDI) is a non-profit research institution recognized worldwide for its discoveries that increase the body's ability to fight disease and to heal.
Board of Trustees
-
Frederick W. Alt, Ph.D.
Scientific Director, Program in Cellular and Molecular Medicine
Children’s Hospital Boston and Immune Disease Institute
Charles A. Janeway Professor of Pediatrics, Children’s Hospital Boston
Investigator, Howard Hughes Medical Institute at Children’s Hospital Boston
Professor of Genetics, Harvard Medical School -
Carleen Brunelli, Ph.D., M.B.A.
Vice President, Research Administration
Children's Hospital Boston -
Robert Carpenter
Chairman
Hydra Biosciences -
Gary Fleisher, M.D.
Pediatrician-in-Chief
Chair, Department of Medicine
Children's Hospital Boston -
David Kirshner
Senior Vice President and Chief Financial Officer
Children's Hospital Boston -
Harvey Lodish, Ph.D.
Member, Whitehead Institute
Professor of Biology and Professor of Bioengineering
Massachusetts Institute of Technology -
James Mandell, M.D.
Chief Executive Officer
Children's Hospital Boston -
Walter M. Pressey
Vice Chair and President
Boston Private Financial Holdings, Inc. -
Enid M. Starr, Esq.
Senior Trial Attorney
Barron & Stadfeld, P.C.

